NMIBC: Clinical Trials

1 trial for NMIBC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow NMIBC: new trials by email Literature Review of NMIBC trials Research Report on NMIBC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
Pemigatinib - Bladder Cancer, NMIBC
Phase 2Active not recruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins302020-10-022026-11-16

Narrower conditions

Carcinoma, Transitional Cell (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Carcinoma (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)

Interventions

pemigatinib (1)

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (1)

Top investigators

Noah M Hahn, MD (1)